Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer’s Disease

[1]  J. Morales-Garcia,et al.  Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease , 2019, International journal of molecular sciences.

[2]  P. Reddy,et al.  Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity , 2018, Human molecular genetics.

[3]  M. Monteiro,et al.  Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1 , 2018, Oxidative medicine and cellular longevity.

[4]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[5]  Winnie S. Liang,et al.  Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease , 2018, Molecular Neurobiology.

[6]  Ana Martínez,et al.  Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition , 2018, Alzheimer's Research & Therapy.

[7]  J. Strosznajder,et al.  Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders. , 2018, Biochimica et biophysica acta. Molecular cell research.

[8]  Yixin Li,et al.  SIRT1/PGC-1α Signaling Promotes Mitochondrial Functional Recovery and Reduces Apoptosis after Intracerebral Hemorrhage in Rats , 2018, Front. Mol. Neurosci..

[9]  W. Lukiw,et al.  Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer’s disease (AD) and Age-Related Macular Degeneration (AMD) , 2018, Cellular and Molecular Neurobiology.

[10]  A. Adamczyk,et al.  Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity , 2018, Journal of Neuroinflammation.

[11]  R. Swerdlow.  Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[12]  P. Reddy,et al.  Aqua-soluble DDQ reduces the levels of Drp1 and A&bgr; and inhibits abnormal interactions between A&bgr; and Drp1 and protects Alzheimer’s disease neurons from A&bgr;- and Drp1-induced mitochondrial and synaptic toxicities , 2017, Human molecular genetics.

[13]  Maxim N. Artyomov,et al.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease , 2017, Cell.

[14]  W. Lukiw,et al.  Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity , 2017, Molecular Neurobiology.

[15]  A. Grimm,et al.  Brain aging and neurodegeneration: from a mitochondrial point of view , 2017, Journal of neurochemistry.

[16]  L. Saso,et al.  Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease , 2017, Drug design, development and therapy.

[17]  Y. Zhao,et al.  Alterations in micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer’s Disease (AD) Hippocampal CA1 , 2017, Journal of Alzheimer's disease & Parkinsonism.

[18]  K. Green,et al.  Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models , 2017, Brain, Behavior, and Immunity.

[19]  L. Polito,et al.  Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease , 2017 .

[20]  Ramesh Kandimalla,et al.  Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. , 2016, Human molecular genetics.

[21]  J. Strosznajder,et al.  Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders , 2016, Neurochemical Research.

[22]  De-Pei Liu,et al.  SIRT1 deacetylates the cardiac transcription factor Nkx2.5 and inhibits its transcriptional activity , 2016, Scientific Reports.

[23]  R. Strosznajder,et al.  Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases. , 2016, Folia neuropathologica.

[24]  Ramesh Kandimalla,et al.  Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. , 2016, Biochimica et biophysica acta.

[25]  A. Najafi,et al.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. , 2016, Brain : a journal of neurology.

[26]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[27]  H. Lassmann,et al.  Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. , 2016, Biochimica et biophysica acta.

[28]  T. Ekblad,et al.  Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide Bioisosteres , 2016, Chemical biology & drug design.

[29]  Joseph E. Parisi,et al.  Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease , 2016, Scientific Reports.

[30]  M. Meyer-Luehmann,et al.  Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures , 2015, Scientific Reports.

[31]  J. Strosznajder,et al.  The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins , 2015, PloS one.

[32]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[33]  S. Mori,et al.  Sirtuin 1 activator SRT2104 protects Huntington's disease mice , 2014, Annals of clinical and translational neurology.

[34]  F. Metzger,et al.  Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. , 2014, Cell metabolism.

[35]  R. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. , 2014, Biochimica et biophysica acta.

[36]  Weiwei Dang.  The controversial world of sirtuins. , 2014, Drug discovery today. Technologies.

[37]  B. Palmier,et al.  Neurological and Histological Consequences Induced by In Vivo Cerebral Oxidative Stress: Evidence for Beneficial Effects of SRT1720, a Sirtuin 1 Activator, and Sirtuin 1-Mediated Neuroprotective Effects of Poly(ADP-ribose) Polymerase Inhibition , 2014, PloS one.

[38]  Walter J. Lukiw,et al.  Circular RNA (circRNA) in Alzheimer's disease (AD) , 2013, Front. Genet..

[39]  E. Bossy‐Wetzel,et al.  Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration , 2013, Front. Aging Neurosci..

[40]  L. Guarente,et al.  The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling , 2013, Cell.

[41]  R. Patel,et al.  Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress , 2013, Cell Death and Disease.

[42]  N. Inestrosa,et al.  Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders? , 2013, PloS one.

[43]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[44]  A. M. van der Bliek,et al.  Mitochondrial Fission, Fusion, and Stress , 2012, Science.

[45]  V. Pertegato,et al.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells , 2012, Nature Protocols.

[46]  J. Götz,et al.  Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio. , 2012, Antioxidants & redox signaling.

[47]  A. Adamczyk,et al.  Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease , 2012, Molecular Neurobiology.

[48]  P. Reddy,et al.  Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. , 2011, Human molecular genetics.

[49]  L. Guarente,et al.  The SirT3 divining rod points to oxidative stress. , 2011, Molecular cell.

[50]  T. Wenz.  Mitochondria and PGC-1α in Aging and Age-Associated Diseases , 2011, Journal of aging research.

[51]  J. Auwerx,et al.  PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. , 2011, Cell metabolism.

[52]  E. Galea,et al.  Frontiers in Aging Neuroscience Aging Neuroscience Epidemiological Data and Clinical Trials , 2022 .

[53]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[54]  A. Eckert,et al.  Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects , 2010, Molecular Neurobiology.

[55]  G. Landreth,et al.  Microglia and inflammation in Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.

[56]  V. Perry,et al.  Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.

[57]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[58]  George Perry,et al.  The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.

[59]  D. Bennett,et al.  Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[60]  G. Small,et al.  Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[61]  C. Deng,et al.  SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expression , 2008, International journal of biological sciences.

[62]  Á. Simonyi,et al.  Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons , 2008, Journal of neurochemistry.

[63]  J. McCaffery,et al.  Mitochondrial Fusion Protects against Neurodegeneration in the Cerebellum , 2007, Cell.

[64]  C. Masters,et al.  Copper‐dependent inhibition of cytochrome c oxidase by Aβ1−42 requires reduced methionine at residue 35 of the Aβ peptide , 2006 .

[65]  J. Quinn,et al.  Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.

[66]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[67]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[68]  C. Masters,et al.  Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide. , 2006, Journal of neurochemistry.

[69]  L. Mucke,et al.  SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling* , 2005, Journal of Biological Chemistry.

[70]  Y. Lyubchenko,et al.  Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease , 2005, Neurological research.

[71]  C. Masters,et al.  Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.

[72]  L. Mucke,et al.  SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. , 2005, The Journal of biological chemistry.

[73]  A. Hilliker,et al.  RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Mark A. Smith,et al.  Alzheimer Disease and Oxidative Stress , 2002, Journal of Biomedicine and Biotechnology.

[75]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[76]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[77]  H. Möller,et al.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.

[78]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[79]  A. Nunomura,et al.  Oxidative stress in Alzheimers disease , 2000 .

[80]  M. Matzuk,et al.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Beal,et al.  Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.

[82]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.